Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

TGA Approval

WINGLORE ipilimumab (rch) 200mg in 40mL (5mg/mL) concentrate solution for IV infusion vial (174327)

ARTG ID

174327

ARTG Name

WINGLORE ipilimumab (rch) 200mg in 40mL (5mg/mL) concentrate solution for IV infusion vial

Sponsor

Bristol-Myers Squibb Australia Pty Ltd

ARTG Date

July 4, 2011

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Bristol-Myers Squibb Australia Pty Ltd

Sponsor Item Name

BRISTOL-MYERS SQUIBB AUSTRALIA PTY LTD

Active Ingredients

Ingredient Name

Ipilimumab

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy